Sentences with phrase «with current share price»

But shhhh... I'm OK with the current share price — it presents the company (and me) with attractive share (re) purchase opportunities!

According to finbox the fair value would be at 139.74 USD that means with the current share price the stock seems to be undervalued and that there is still some upside potential.

Not exact matches

Gerstner said he thinks United Airlines stock is worth double or triple its current share price of about $ 75, or even more, with his target price at as much as $ 235 a share.

Corey Davis, an analyst with investment firm Jefferies & Co., estimates shares will rise to $ 1.44 in 2014 (about a 60 cents jump from the current price) after the combined company has a full year of operations under its belt.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

With virtually identical market capitalization (the price it would take to buy all shares of a company's outstanding common stock at the current market value), what exactly is an investor in each respective firm getting for his or her money?

With its 19 % ROIC, WU should be valued at $ 31 / share according to Figure 1, 64 % above its current stock price.

As a result of these agreements, Retrophin paid $ 200,000 in cash and issued 581,000 shares to MSMB investors, resulting in a benefit to Shkreli of over $ 17.3 million (at current market prices), and is embroiled in an arbitration with Rosenfeld in which Rosenfeld is seeking $ 1,650,000.

(i) by causing Retrophin to commence a litigation against Doe in order to coerce Doe into giving Shkreli Doe's Fearnow Shares, and by causing Retrophin to enter into a settlement with Doe whereby Retrophin paid $ 100,000 and Doe delivered 50,000 shares to Shkreli, resulting in a benefit to Shkreli of more than $ 1.4 million (at current market prShares, and by causing Retrophin to enter into a settlement with Doe whereby Retrophin paid $ 100,000 and Doe delivered 50,000 shares to Shkreli, resulting in a benefit to Shkreli of more than $ 1.4 million (at current market prshares to Shkreli, resulting in a benefit to Shkreli of more than $ 1.4 million (at current market prices).

(j) by causing Retrophin to enter into a settlement with Jackson Su whereby Retrophin paid $ 107,638 and Shkreli received 126,388 shares, resulting in a benefit to Shkreli of more than $ 3.7 million (at current market prices).

Next we compare our value (price) per share with the current trading price per share on the stock market.

Given the absence of a public trading market of our common stock, and in accordance with the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately - Held Company Equity Securities Issued as Compensation, our board of directors exercised reasonable judgment and considered numerous and subjective factors to determine the best estimate of fair value of our common stock, including independent third - party valuations of our common stock; the prices at which we sold shares of our convertible preferred stock to outside investors in arms - length transactions; the rights, preferences, and privileges of our convertible preferred stock relative to those of our common stock; our operating results, financial position, and capital resources; current business conditions and projections; the lack of marketability of our common stock; the hiring of key personnel and the experience of our management; the introduction of new products; our stage of development and material risks related to our business; the fact that the option grants involve illiquid securities in a private company; the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company given the prevailing market conditions and the nature and history of our business; industry trends and competitive environment; trends in consumer spending, including consumer confidence; and overall economic indicators, including gross domestic product, employment, inflation and interest rates, and the general economic outlook.

Pachter has consistently been one of the most bearish analysts on Wall Street, rating the company underperform with a $ 40 price target, compared to a current share price of around $ 100.

RW: With the current interest in buying electric cars, plus more wind turbines being built and growing Chinese infrastructure, does this mean the fundamentals are falling into place for rising copper prices and copper company share values?

Research firm Off Wall Street Consulting Group Inc. initiated coverage on the shares with a long - term sell and a $ 25 price target, 29 percent below the current price.

A company with a market capitalization near the low end of those publicly traded — calculated by taking a firm's current share price and multiplying that figure by the total number of shares outstanding - is termed small - cap.

At its current valuation of ~ $ 500 / share, AZO stands out with a price to economic book value ratio of only 1, which implies that the company will never grow NOPAT from its current level.

With current quarterly share price growth of 12.5 percent and five - year growth projected to be 13 percent, CarMax is a good long - term play.

When dealing with growth stocks, the P / E ratio is the current price per share divided by earnings per share (also known as the EPS).

When asked if Syrah was a takeover target at its current share price, Mr Slifirski said: «Anytime you see a company with a world class resource in terms of scale, quality and position on the cost curve, which is exposed to a disruptive technology and has an open share register, it makes absolute sense as a takeover target.»

«We think the recently lowered dividend payout is sustainable, providing investors with an attractive 6 per cent fully franked yield at current prices... we view the risks facing Telstra as more than reflected in the current stock price, trading at 12 times forward earnings per share and 5.5 times earnings before interest, tax, depreciation and amortisation,» the analysts said.

Even though the city and state (via the MTA) have traditionally shared the cost of free student MetroCards, the current push for a similar program with half - price cards for low - income NYC residents has focused on the mayor, not the governor.

These are, with their current forward dividend yields, forward P / E ratios and 52 - week share price movements through December 6:

«Please sell xxx shares on the US market to settle in US$ funds with a limit order at the current bid price.»

For example, if you own stock that you bought for $ 30 a share with a current market price of $ 50, you could buy a put contract with an exercise price of $ 45.

Be wary of any blue chip stocks with unusually high dividend yields: Investors should avoid judging a company based solely on its dividend yield (the percentage you get when you divide a company's current yearly payment by its share price).

So although panic selling can disrupt the order book, especially during periods of illiquidity, with the current structure «the stock market» being based off of three composite indexes, can never crash, because there will always exist a company that is not exposed to broad market fluctuations and will be performing better by fundamentals and share price.

Say I have 100 shares of Rs 10 each with current price of Rs 8 which resulted into short term capital loss of Rs 200.

Prospect shares yield 11 % at current prices, which is about in line with its new originations.

If I put a sell order with a limit price of $ 26.85 (higher than the current price), the order won't get filled until the stock price goes up a bit and someone agrees to pay $ 26.85 for my REI shares.

So with today's low interest rates, investors are paying more attention to dividend yields (a company's total annual dividends paid per share divided by the current stock price).

What you may realize, is regardless of how far off the current market share price is from its peak... your new dollars may be better allocated in another investment with a higher «earnings yield».

This then leaves us with 18 % discount, given the current market price of $ 2.65 / share.

Consequently, the shares appear reasonably priced with the current blended P / E ratio of 17.7.

The current price is near the lowest point over the last year, and most analysts have a valuation of around $ 40 to $ 41 per share (roughly what I paid), with an overall «hold» rating.

And with current weakness in the share price, an entry point to this dream is looking more and more attractive — especially since the weakness in the stock price is more a reflection of rising interest rates than of actual company fundamentals.

Also included are all other companies covered to date (with updated share prices, FX rates, etc. as of Sep 10th)-- and, of course, I've ranked all 75 companies according to their current Upside Potential.

I'm not expecting the share price to do much until the current deal with Walgreens is consummated (or not), so I think there is ample opportunity to pick up shares at levels slightly below where the shares are currently trading.

Therefore, the real purpose of continually updating share prices with each post / file is to basically allow me to rank all shares together (pretty much apples to apples) by current Upside Potential — this will offer an expanding real - time menu of Irish stocks to consider as we progress.

With my average cost below $ 6 a share and the current price over $ 10, the stock has nicely met and beat my target IRR.

So with limited potential upside and significant downside (if the remerging of the entities can not be achieved), I will be holding my position and possibly even pruning it if Mr. Market becomes exuberant, rather than increasing my exposure, even though, at the current share price of $ 3.07, there is a 16 % upside to the implied liquidation value.

Currently I pick a stop loss position just below a previous low, then using the difference between the current price and my stop loss price I work out how many shares I can buy with a 0.75 % stop loss amount of my total portfolio.

James Marlay of Livewire presents with guests Steve Johnson from Forager Funds and Roger Montgomery of Montgomery Investments about their current views on some big companies who's share prices have fallen recently.

an options trader holds the shares of IBM with the current market price of $ 160, which he thinks is overpriced and the market will soon go down.

He placed a «call» option with a payoff of 70 %, or $ 280, if the share price was trading above the current price of $ 1.50 at the expiry time.

And noting NTR's current $ 2.45 share price, my scenario would leave shareholders with a $ 0.10 per New NTR share cost base.

wait until the current work - over programme and oil flow testing has been completed in the next few weeks and then go back to the drawing board with your pathetic blog, as I'm sure you're really going to be angry when you see the share price in double figures next month!!!

The iShares US Fundamental Index ETF (CLU) leads the pack with an estimated distribution of $ 3.47 per share, equal to roughly 10 % of the ETF's current price.

A farm - out would obviously help, as would increasing production, but ending up with at least a year of cash - burn on hand (and / or positive cash flow)-- however that might occur — is what could really transform (i.e. multiply) the current PTR share price.

But I remain confident Record's current fundamentals (& subsequent technicals) will still propel the share price significantly higher from here (with a potential significant long - term AUME growth kicker if / when volatility elevates & global macro / FX policies diverge more radically).